CSF corticotropin-releasing hormone and somatostatin in major depression: response to antidepressant treatment and relapse
- 30 June 1992
- journal article
- Published by Elsevier BV in European Neuropsychopharmacology
- Vol. 2 (2), 107-113
- https://doi.org/10.1016/0924-977x(92)90019-5
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Neuropeptide Concentrations in the Cerebrospinal Fluid of Depressed Patients Treated with Electroconvulsive TherapyThe British Journal of Psychiatry, 1991
- Delayed effects of chronic cortisol treatment on brain and plasma concentrations of corticotropin (ACTH) and β-endorphinBrain Research, 1989
- Elevated CSF CRF in suicide victimsBiological Psychiatry, 1989
- Implications of altered limbic‐hypothalamicpituitary‐adrenocortical (LHPA)‐function for neurobiology of depressionActa Psychiatrica Scandinavica, 1988
- The Role of Corticotropin-Releasing Factor in the Pathogenesis of Major DepressionPharmacopsychiatry, 1988
- Clinical studies with corticotropin releasing factor: implications for the diagnosis and pathophysiology of depression, Cushing's disease, and adrenal insufficiencyPsychoneuroendocrinology, 1985
- Elevated Concentrations of CSF Corticotropin-Releasing Factor-Like Immunoreactivity in Depressed PatientsScience, 1984
- Low levels of somatostatin in human CSF mark depressive episodesPsychoneuroendocrinology, 1984
- The Dexamethasone Suppression Test for MelancholiaThe British Journal of Psychiatry, 1982
- A theory of convulsive therapy in endogenous depression: Significance of hypothalamic functionsPsychiatry Research, 1980